表紙
市場調査レポート

下腿潰瘍:世界の治験レビュー

Leg Ulcers Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 240559
出版日 ページ情報 英文 82 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
下腿潰瘍:世界の治験レビュー Leg Ulcers Global Clinical Trials Review, H1, 2014
出版日: 2014年02月10日 ページ情報: 英文 82 Pages
概要

当レポートでは、下腿潰瘍治療薬に関する治験動向について、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報などをまとめ、概略以下の構成でお届けします。

イントロダクション

地域別の治験動向

  • 国別の治験動向
    • アジア太平洋地域の主要5ヶ国
    • 欧州の主要5ヶ国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験

G7諸国における治験:治験状況別

相別の治験状況

現在進行中の治験

一定期間に採用された被験者

有望なスポンサー

  • 下腿潰瘍治療薬の治験に参加している主要企業

有望な治療薬の比較

治験プロファイル

  • 主要企業の治験概要
    • Smith & Nephew Plc
    • Tissue Therapies Limited
    • Shire Plc
    • NB Therapeutics, Inc.
    • Johnson & Johnson
    • CytoTools AG
    • CoDa Therapeutics, Inc.
    • AUS Bio Limited
    • Altrika Ltd
    • Air Liquide S.A.
  • 主要大学/研究所/病院の治験概要
    • Department of Health, South Africa
    • Department of Health, UK
    • University of Leipzig
    • Assistance Publique - Hopitaux de Paris
    • University of Pennsylvania
    • Medical University of South Carolina
    • Southwest Regional Wound Care Center
    • University of York
    • UMC Utrecht Holding BV
    • Queen's University

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC1960CTIDB

GlobalData's clinical trial report, "Leg Ulcers Global Clinical Trials Review, H1, 2014" provides data on the Leg Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leg Ulcers. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leg Ulcers. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Leg Ulcers
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Leg Ulcers to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Leg Ulcers to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Leg Ulcers
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Leg Ulcers Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Leg Ulcers
    • Jul 04, 2013: Pergamum Reports Positive Preliminary Efficacy Results from a Phase I/II Study of LL-37 in Patients with Chronic Leg Ulcers
    • Oct 15, 2011: Photopharmica Announces Phase II Clinical Study Results Of PPA-904 In Chronic Leg Ulcers
    • Jul 04, 2007: IP Group Spin-Out Company, Photopharmica, Announces Successful Phase II Data.
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Smith & Nephew Plc
      • Clinical Trial Overview of Smith & Nephew Plc
      • Tissue Therapies Limited
      • Clinical Trial Overview of Tissue Therapies Limited
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • NB Therapeutics, Inc.
      • Clinical Trial Overview of NB Therapeutics, Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • CytoTools AG
      • Clinical Trial Overview of CytoTools AG
      • CoDa Therapeutics, Inc.
      • Clinical Trial Overview of CoDa Therapeutics, Inc.
      • AUS Bio Limited
      • Clinical Trial Overview of AUS Bio Limited
      • Altrika Ltd
      • Clinical Trial Overview of Altrika Ltd
      • Air Liquide S.A.
      • Clinical Trial Overview of Air Liquide S.A.
    • Clinical Trial Overview of Top Institutes / Government
      • Department of Health, South Africa
      • Clinical Trial Overview of Department of Health, South Africa
      • Department of Health, UK
      • Clinical Trial Overview of Department of Health, UK
      • University of Leipzig
      • Clinical Trial Overview of University of Leipzig
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • Medical University of South Carolina
      • Clinical Trial Overview of Medical University of South Carolina
      • Southwest Regional Wound Care Center
      • Clinical Trial Overview of Southwest Regional Wound Care Center
      • University of York
      • Clinical Trial Overview of University of York
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
      • Queen's University
      • Clinical Trial Overview of Queen's University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Leg Ulcers Therapeutics, Global, Clinical Trials by Region, 2014*
  • Leg Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Leg Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Leg Ulcers to Dermatology Clinical Trials, G7 Countries (%), 2014*
  • Leg Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Leg Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Leg Ulcers to Dermatology Clinical Trials, E7 Countries (%), 2014*
  • Leg Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Leg Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Leg Ulcers Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Leg Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Leg Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Leg Ulcers Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Leg Ulcers Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Leg Ulcers Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Leg Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Smith & Nephew Plc, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Tissue Therapies Limited, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by NB Therapeutics, Inc., 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by CytoTools AG, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by CoDa Therapeutics, Inc., 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by AUS Bio Limited, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Altrika Ltd, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Air Liquide S.A., 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Regional Wound Care Center, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by University of York, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014*
  • Leg Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014*

List of Figures

  • Leg Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Leg Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Leg Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Leg Ulcers Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Leg Ulcers to Dermatology Clinical Trials, G7 Countries (%), 2014*
  • Leg Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Leg Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Leg Ulcers to Dermatology Clinical Trials, E7 Countries (%), 2014*
  • Leg Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Leg Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Leg Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Leg Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Leg Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Leg Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top